Skip to main content

Full text of "USPTO Patents Application 10025367"

See other formats


Page 1 of 4 



OIPE 



RAW SEQUENCE LISTING DATE: 01/16/2002 

PATENT APPLICATION: US/10/025,367 TIME: 18:42:57 

Input Set : A:\15120.asc 

Output Set: N:\CRF3\01162002\J025367.raw 0O6S Not Comply 

U^T^^ JLJJbh Corrected Diskette Needec 

8 <110> APPLICANT: Viaxxel Biotech GmbH 

10 <120> TITLE OF INVENTION: Compounds that affect CD83 expression, pharmaceutical 

11 compositions comprising said compounds and methods for 

12 identifying said compounds 
14 <130> FILE REFERENCE: 84201 

, 16 <140> CURRENT APPLICATION NUMBER: US/10/025,3 67 
17 <141> CURRENT FILING DATE: 2001-12-19 
19 <160> NUMBER OF SEQ ID NOS : 27 
21 <170> SOFTWARE: Patentln Ver. 2.1 



ERRORED SEQUENCES 

1062 <210> SEQ ID NO: 27 

1063 <211> LENGTH: 380 

1064 <212> TYPE: PRT 

1065 <213> ORGANISM: Homo sapiens 
1067 <400> SEQUENCE: 27 



1068 


Met 


Val 


Met 


He 


He 


Ser 


Thr 


Met Glu 


Pro 


Gin 


Val 


Ser 


Asn 


Gly 


Pro 


1069 


1 








5 








10 










15 




1071 


Thr 


Ser 


Asn 


Thr 


Ser 


Asn 


Gly 


Pro Ser 


Ser 


Asn 


Asn 


Arg 


Asn 


Cys 


Pro 


1072 








20 








25 










30 






1074 


Ser 


Pro 


Met 


Gin 


Thr 


Gly 


Ala 


Thr Thr 


Asp 


Asp 


Ser 


Lys 


Thr 


Asn 


Leu 


1075 






35 










40 








45 








1077 


He 


Val 


Asn 


Tyr 


Leu 


Pro 


Gin 


Asn Met 


Thr 


Gin 


Glu 


Glu 


Phe 


Arg 


Ser 


1078 




50 










55 








60 










1080 


Leu 


Phe 


Gly 


Ser 


He 


Gly 


Glu 


He Glu 


Ser 


Cys 


Lys 


Leu 


Val 


Arg 


Asp 


1081 


65 










70 








75 










80 


1083 


Lys 


He 


Thr Gly Gin 


Ser 


Leu 


Gly Tyr 


Gly 


Phe 


Val 


Asn 


Tyr 


He 


Asp 


1084 










85 








90 










95 




1086 


Pro 


Lys 


Asp 


Ala 


Glu 


Lys 


Ala 


He Asn 


Thr 


Leu 


Asn 


Gly 


Leu 


Arg 


Leu 


1087 








100 








105 










110 






1089 


Gin 


Thr 


Lys 


Thr 


He 


Lys 


Val 


Ser Tyr 


Ala 


Arg 


Pro 


Ser 


Ser 


Ala 


Ser 


1090 






115 










120 








125 








1092 


He Arg 


Asp 


Ala 


Asn 


Leu 


Tyr 


Val Ser 


Gly Leu 


Pro 


Lys 


Thr 


Met 


Thr 


1093 




130 










135 








140 










1095 


Gin 


Lys 


Glu 


Leu 


Glu 


Gin 


Leu 


Phe Ser 


Gin 


Tyr Gly 


Arg 


He 


He 


Thr 


1096 


145 










150 








155 










160 


1098 


Ser 


Arg 


He 


Leu 


Val 


Asp 


Gin 


Val Thr 


Gly Val 


Ser 


Arg 


Gly 


Val 


Gly 


1099 










165 








170 










175 




1101 


Phe 


He 


Arg 


Phe 


Asp 


Lys 


Arg 


He Glu 


Ala 


Glu 


Glu 


Ala 


He 


Lys 


Gly 


1102 








180 








185 










190 






1104 


Leu 


Asn 


Gly 


Gin 


Lys 


Pro 


Ser Gly Ala 


Thr 


Glu 


Pro 


He 


Thr 


Val 


Lys 


1105 






195 










200 








205 








1107 


Phe 


Ala 


Asn 


Asn 


Pro 


Ser 


Gin 


Lys Ser 


Ser 


Gin 


Ala 


Leu 


Leu 


Ser 


Gin 


1108 




210 










215 








220 











file://C:\CRF3\OutholcKVsrJ025367.htm 



1/16/02 



RAW SEQUENCE LISTING DATE: 01/16/2002 

PATENT APPLICATION: US/10/025,367 TIME: 18:42:58 



Input Set : A:\15120.asc 

Output Set: N:\CRF3\01162002\J025367.raw 



1110 


Leu 


Tyr 


Gin 


Ser 


Pro 


Asn 


Arg 


Arg 


Tyr 


Pro 


Gly 


Pro 


Leu 


His 


His Gin 


1111 


225 










230 










235 








240 


1113 


Ala 


Gin 


Arg 


Phe 


Arg 


Leu 


Asp 


Asn 


Leu 


Leu 


Asn 


Met 


Ala 


Tyr 


Gly Val 


1114 










245 










250 










255 


1116 


Lys 


Arg 


Leu 


Met 


Ser 


Gly 


Pro 


Val 


Pro 


Pro 


Ser 


Ala 


Cys 


Ser 


Pro Arg 


1117 








260 










265 










270 




1119 


Phe 


Ser 


Pro 


He 


Thr 


He 


Asp 


Gly 


Met 


Thr 


Ser 


Leu 


Val 


Gly 


Met Asn 


1120 






275 










280 










285 






1122 


He 


Pro 


Gly 


His 


Thr 


Gly 


Thr 


Gly 


Trp 


Cys 


He 


Phe 


Val 


Tyr 


Asn Leu 


1123 




290 










295 










300 








1125 


Ser 


Pro 


Asp 


Ser 


Asp 


Glu 


Ser 


Val 


Leu 


Trp 


Gin 


Leu 


Phe 


Gly 


Pro Phe 


1126 


305 










310 










315 








320 


1128 


Gly 


Ala 


Val 


Asn 


Asn 


Val 


Lys 


Val 


He 


Arg 


Asp 


Phe 


Asn 


Thr 


Asn Lys 


1129 










325 










330 










335 


1131 


Cys 


Lys 


Gly 


Phe 


Gly 


Phe 


Val 


Thr 


Met 


Thr 


Asn 


Tyr 


Asp 


Glu 


Ala Ala 


1132 








340 










345 










350 




1134 


Met 


Ala 


He 


Ala 


Ser 


Leu 


Asn 


Gly 


Tyr 


Arg 


Leu 


Gly 


Asp 


Arg 


Val Leu 


1135 






355 










360 










365 






1137 


Gin 


Val 


Ser 


Phe 


Lys 


Thr 


Asn 


Lys 


Ala 


His 


Lys 


Ser 








1138 




370 










375 










380 








E--> 1144 

































file://C:\CRF3\Outhold\VsrJ025367.htm 



VERIFICATION SUMMARY DATE: 01/16/2002 

PATENT APPLICATION: US/10/025,3 67 TIME: 18:42:59 



Input Set : A:\15120.asc 

Output Set: N:\CRF3\01162002\J025367.raw 

L:l M:259 W: Allowed number of lines exceeded, (1) GENERAL INFORMATION : 
L:16 M:270 C: Current Application Number differs, Replaced Application Number 
L:17 M:271 C: Current Filing Date differs, Replaced Current Filing Date 
L:1144 M:332 E: (32) Invalid/Missing Amino Acid Numbering, SEQ ID:27 



file://C:\CRF3\OutholcKVsrJ025367.htm